Journal of Experimental Medicine (JEM) | Rockefeller University Press

Skip Nav Destination

125th Anniversary

In this series, authors revisit seven landmark JEM articles that have had a lasting impact
JEM Immunology Collection 2021
Inhibition of IL1β release prevents VIPN
Neuronal GRM8 in CNS inflammation
Role of Regnase-1 in B cells

RUP response to COVID-19 crisis: Learn about the steps we are taking and find relevant content.

Newest Articles

Brief Definitive Report

| May 12 2021

Mc4r mediates antipsychotics-induced weight gain

Li Li, Eun-Seon Yoo, Xiujuan Li, Steven C. Wyler, Xiameng Chen, Rong Wan, Amanda G. Arnold, Shari G. Birnbaum, Lin Jia, Jong-Woo Sohn, Chen Liu

Li et al. develop a new mouse model that recapitulates risperidone-induced metabolic syndrome. Using a combination of transcriptomic, genetic, and electrophysiological approaches, they show that risperidone targets hypothalamic MC4Rs to cause weight gain and that setmelanotide, an MC4R agonist, mitigates its metabolic side effects.

Article

| May 11 2021

LILRB4 inhibits immune responses in solid tumor

Naveen Sharma, Oluwatomisin T. Atolagbe, Zhongqi Ge, James P. Allison

LILRB4 strongly suppresses tumor immunity, and LILRB4 blockade alleviates that suppression to provide antitumor efficacy. The authors show that LILRB4 is expressed largely on TAMs and suppresses antitumor immunity. Genetic deletion of LILRB4 or anti-LILRB4 antibody treatment modulates T cells to an effector phenotype and TAMs to a less immunosuppressive phenotype and increases survival against tumor challenge.

Article

| May 11 2021

Cbl-b is necessary for T cell anergy

Trang T.T. Nguyen, Zhi-En Wang, Lin Shen, Andrew Schroeder, Walter Eckalbar, Arthur Weiss

T cell anergy is an important peripheral tolerance mechanism to prevent autoimmunity. Nguyen et al. find that T cell anergy develops in the periphery, not in the thymus, and depends upon Cbl-b but not Grail or PD-1.

Article

| May 10 2021

Cholesterol in microglia and neuropathic pain

Juliana M. Navia-Pelaez, Soo-Ho Choi, Luciano dos Santos Aggum Capettini, Yining Xia, Ayelet Gonen, Colin Agatisa-Boyle, Lauriane Delay, Gilson Gonçalves dos Santos, Glaucilene F. Catroli, Jungsu Kim, Jenny W. Lu, Benjamin Saylor, Holger Winkels, Christopher P. Durant, Yanal Ghosheh, Graham Beaton, Klaus Ley, Irina Kufareva, Maripat Corr, Tony L. Yaksh, Yury I. Miller

In a mouse model of chemotherapy-induced peripheral neuropathy, spinal microglia are characterized by the presence of inflammarafts—enlarged, cholesterol-enriched lipid rafts—which organize the inflammatory response. Manipulation of specific mechanisms regulating cholesterol metabolism normalizes inflammarafts and reprograms microglia, resulting in long-lasting alleviation of neuropathic pain.

Article

| May 10 2021

CD8 + T cell specific participation of PLCβ4

Miwa Sasai, Ji Su Ma, Masaaki Okamoto, Kohei Nishino, Hikaru Nagaoka, Eizo Takashima, Ariel Pradipta, Youngae Lee, Hidetaka Kosako, Pann-Ghill Suh, Masahiro Yamamoto

Sasai, Ma, et al. demonstrate that PLCβ4 is specifically required for TCR signaling in CD8+ T cells but not CD4+ T cells, indicating that TCR signaling of CD8+ T cells is qualitatively distinct from that of CD4+ T cells.

Article

| May 10 2021

DNMT3A haploinsufficiency in mature immune cells

Jung-Yeon Lim, Sascha H. Duttke, Turner S. Baker, Jihye Lee, Kristyne J. Gambino, Nicholas J. Venturini, Jessica Sook Yuin Ho, Simin Zheng, Yesai S. Fstkchyan, Vinodh Pillai, David C. Fajgenbaum, Ivan Marazzi, Christopher Benner, Minji Byun

Acquired mutations in DNMT3A are common in blood, but their impacts on mature immune cells are poorly understood. Lim et al. demonstrate that DNMT3A defects cause dichotomous DNA methylation defects at enhancers, leading to altered enhancer activity and abnormal gene expression in mature immune cells.

Article

| May 07 2021

CD1a capture of lipid blockers

Rachel N. Cotton, Marcin Wegrecki, Tan-Yun Cheng, Yi-Ling Chen, Natacha Veerapen, Jérôme Le Nours, Dennis P. Orgill, Bohdan Pomahac, Simon G. Talbot, Richard Willis, John D. Altman, Annemieke de Jong, Ildiko Van Rhijn, Rachael A. Clark, Gurdyal S. Besra, Graham Ogg, Jamie Rossjohn, D. Branch Moody

CD1a is expressed on Langerhans cells, where it presents lipid antigens to activate T cells. However, skin cells also produce a natural lipid that binds CD1a and blocks T cell response as a mechanism to down-regulate autoreactivity.

Browse All >

Related Articles from Rockefeller University Press

NF-κB inhibition in keratinocytes causes RIPK1-mediated necroptosis and skin inflammation

Snehlata Kumari ... Manolis Pasparakis | Life Sci. Alliance

TNFR1 was found to cause skin inflammation in mice with epidermal keratinocyte-specific ablation of IKK2 or of both the NF-kB subunits RelA and cRel by triggering RIPK1-dependent, RIPK3-MLKL–mediated necroptosis of keratinocytes.
Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages

Samantha B Kemp ... Marina Pasca di Magliano | Life Sci. Alliance

This study uses biomaterial scaffolds to identify a macrophage gene signature defined by high expression of C1qa, C1qb, and Trem2 that is elevated systemically in mouse and human pancreatic cancer.
DGCR8 deficiency impairs macrophage growth and unleashes the interferon response to mycobacteria

Barbara Killy ... Roland Lang | Life Sci. Alliance

Lack of miRNA biosynthesis in DGCR8-deficient macrophages did not block macrophage differentiation but caused overshooting type I IFN responses to mycobacterial glycolipids.

Current Issue

Volume 218,

Issue 5,

May 3, 2021

View This Issue

Submit Your Research

Manage Email Alerts

Reviews & Opinions

Perspective

| April 27 2021

Rare IEIs in MIS-C and Kawasaki disease?

Vanessa Sancho-Shimizu, Petter Brodin, Aurélie Cobat, Catherine M. Biggs, Julie Toubiana, Carrie L. Lucas, Sarah E. Henrickson, Alexandre Belot, MIS-C@CHGE, Stuart G. Tangye, Joshua D. Milner, Michael Levin, Laurent Abel, Dusan Bogunovic, Jean-Laurent Casanova, Shen-Ying Zhang

SARS-CoV-2 is the trigger of MIS-C, which suggests that other viruses may trigger different forms of Kawasaki disease. The discovery of inborn errors of immunity underlying MIS-C would facilitate that of inborn errors of immunity to viruses underlying Kawasaki disease.

Viewpoint | JEM 125th Anniversary

| April 21 2021